Related Experiment Videos
Endobronchial tuberculous granuloma in children
M Prada Arias1, J A Jardón Bahía, P Rodríguez Barca
1Service of Paediatric Surgery, University Hospital of Santiago de Compostela, Spain. marcosprada@hotmail.com
Summary
Endobronchial tuberculous granuloma is a rare complication in children with tuberculosis (TB). This study highlights its successful diagnosis and treatment via bronchoscopy and medical management, with favorable outcomes.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Pediatric Surgery
Background:
- Endobronchial tuberculosis (TB) is uncommon in children, often arising as a complication of primary TB.
- Endobronchial involvement can manifest in various ways, with granulomas being infrequent.
- This study focuses on a specific, less common presentation: endobronchial tuberculous granuloma in pediatric patients.
Purpose of the Study:
- To report on the diagnosis and treatment of endobronchial tuberculous granuloma in children.
- To evaluate the clinical course and outcomes of these cases.
- To emphasize the importance of considering this condition in pediatric airway obstruction.
Main Methods:
- Retrospective review of 10 pediatric cases of endobronchial tuberculous granuloma treated between 1991 and 2004.
- Diagnosis and removal of granuloma performed via bronchoscopy.
- Standard medical tuberculosis treatment supplemented with a 4-week course of corticosteroids post-removal.
Main Results:
- Ten cases of endobronchial tuberculous granuloma were identified and treated.
- Two cases presented acutely as the initial sign of TB; the rest occurred during or after treatment for primary TB.
- All patients underwent successful bronchoscopic removal and responded well to medical treatment, with no reported complications.
Conclusions:
- Endobronchial tuberculous granuloma, though rare, is a treatable condition in children.
- Bronchoscopy is an effective method for diagnosis and removal.
- This diagnosis should be considered in children with airway obstruction symptoms, particularly those with known or treated tuberculosis.
Related Concept Videos
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories: